| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Renal Physiology, Vol 258, Issue 5 1181-F1187, Copyright © 1990 by American Physiological Society
ARTICLES |
H. R. Brady, B. C. Kone, M. E. Stromski, M. L. Zeidel, G. Giebisch and S. R. Gullans
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.
Oxygen consumption (QO2) and net K+ transport were studied in rabbit proximal tubule suspensions to define the early effects of cisplatin on proximal tubule function. Cisplatin caused dose-dependent inhibition of QO2, which was delayed in onset. The concentration of cisplatin required for inhibition decreased as the duration of exposure was increased [40-min exposure, threshold concentration of 10(-4) M, inhibitor constant (Ki) of 10(-3) M; 4-h exposure, threshold concentration of 3 X 10(-5) M, Ki of 10(-4) M]. Both ouabain-sensitive and ouabain-insensitive QO2 were reduced, indicating inhibition of all adenosinetriphosphatases, including Na(+)- K(+)-ATPase activity. There was a parallel fall in ouabain-sensitive net K+ transport and cytosolic K+ content, confirming the latter observation. Na(+)-K(+)-ATPase activity was unchanged in cell membranes prepared by hypotonic lysis from cisplatin-treated tubules, indicating an indirect cytosol-dependent mechanism of enzyme inhibition. Nystatin-stimulated QO2 was reduced in cisplatin-treated tubules, excluding inhibition of Na+ entry as the mechanism of injury and suggesting mitochondrial injury. The latter was confirmed by measurement of carbonylcyanide-m-chlorophenylhydrazone (CCCP)-uncoupled QO2 in intact cells and ADP-stimulated (state 3) QO2 in digitonin-permeabilized tubules. Furthermore, by maximally stimulating mitochondrial respiration with CCCP and nystatin, it was possible to demonstrate mitochondrial injury at a time when basal QO2 and K+ transport were apparently normal. These data suggest that mitochondrial injury is a central event in cisplatin toxicity to the proximal tubule.
This article has been cited by other articles:
|
|
 |
|
  H. D. C. Francescato, R. S. Costa, F. B. Junior, and T. M. Coimbra Effect of JNK inhibition on cisplatin-induced renal damage Nephrol. Dial. Transplant., August 1, 2007; 22(8): 2138 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Yang, V. Kaushal, S. V. Shah, and G. P. Kaushal Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells Am J Physiol Renal Physiol, June 1, 2007; 292(6): F1710 - F1717. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, I. Kojima, T. Ohse, R. Inagi, T. Miyata, J. R. Ingelfinger, T. Fujita, and M. Nangaku Hypoxia-inducible factor modulates tubular cell survival in cisplatin nephrotoxicity Am J Physiol Renal Physiol, November 1, 2005; 289(5): F1123 - F1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Iwasaki, Y. Adachi, K. Minamino, Y. Suzuki, Y. Zhang, M. Okigaki, K. Nakano, Y. Koike, J. Wang, H. Mukaide, et al. Mobilization of Bone Marrow Cells by G-CSF Rescues Mice from Cisplatin-Induced Renal Failure, and M-CSF Enhances the Effects of G-CSF J. Am. Soc. Nephrol., March 1, 2005; 16(3): 658 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Jia, M. D. Person, J. Dong, J. Shen, S. C. Hensley, J. L. Stevens, T. J. Monks, and S. S. Lau Grp78 is essential for 11-deoxy-16,16-dimethyl PGE2-mediated cytoprotection in renal epithelial cells Am J Physiol Renal Physiol, December 1, 2004; 287(6): F1113 - F1122. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Nowak, P. M. Price, and R. G. Schnellmann Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells Am J Physiol Renal Physiol, September 1, 2003; 285(3): F440 - F450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsuruya, M. Tokumoto, T. Ninomiya, M. Hirakawa, K. Masutani, M. Taniguchi, K. Fukuda, H. Kanai, H. Hirakata, and M. Iida Antioxidant ameliorates cisplatin-induced renal tubular cell death through inhibition of death receptor-mediated pathways Am J Physiol Renal Physiol, August 1, 2003; 285(2): F208 - F218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Cummings and R. G. Schnellmann Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 8 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Park, M. De Leon, and P. Devarajan Cisplatin Induces Apoptosis in LLC-PK1 Cells via Activation of Mitochondrial Pathways J. Am. Soc. Nephrol., April 1, 2002; 13(4): 858 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Townsend and M. H. Hanigan Inhibition of gamma -Glutamyl Transpeptidase or Cysteine S-Conjugate beta -Lyase Activity Blocks the Nephrotoxicity of Cisplatin in Mice J. Pharmacol. Exp. Ther., January 1, 2002; 300(1): 142 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Davis, H. S. Nick, and A. Agarwal Manganese Superoxide Dismutase Attenuates Cisplatin-Induced Renal Injury: Importance of Superoxide J. Am. Soc. Nephrol., December 1, 2001; 12(12): 2683 - 2690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Shiraishi, L. M. Curtis, L. Truong, K. Poss, G. A. Visner, K. Madsen, H. S. Nick, and A. Agarwal Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis Am J Physiol Renal Physiol, May 1, 2000; 278(5): F726 - F736. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
